“Antibody Response to Breakthrough SARS-CoV-2 Infection in ‘booster’ Vaccinated Patients With Multiple Myeloma According to B T NK Lymphocyte Absolute Counts and Anti-CD38 Treatments”. Mediterranean Journal of Hematology and Infectious Diseases 16, no. 1 (February 29, 2024): e2024022. Accessed April 30, 2026. https://www.mjhid.org/mjhid/article/view/5618.